Our DNA is constantly under threat — from cell division errors to external factors like sunlight and smoking. Fortunately, ...
Researchers have identified an ancient RNA-guided system that can target DNA, potentially expanding the genome-editing toolbox.
Scotiabank began coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a report issued on Friday morning, ...
Plants survive cold by adjusting at cellular level. Scientists discovered that the PORCUPINE protein helps plants adapt to ...
ZME Science on MSN5h
Scientists Discover a New Form of Inheritance That Doesn’t Involve DNA“Matthew really opened up a new form of epigenetic inheritance,” says Dr. Brent Derry, Eroglu’s supervisor. “He found that ...
Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines that directly target RNA, today announced that the company will present ...
Fintel on MSN2d
Scotiabank Initiates Coverage of Avidity Biosciences (RNA) with Sector Outperform RecommendationFintel reports that on March 7, 2025, Scotiabank initiated coverage of Avidity Biosciences (NasdaqGM:RNA) with a Sector ...
One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced presentation of preclinical data supporting the advancement of ...
One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...
RNA sequencing has emerged as a powerful supplement to DNA sequencing for Mendelian disease diagnosis, but clinical ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) released topline results from Part 2 of a Phase 1/2 study of ARO-C3, the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback